Biotech SMEs – statistics & facts

Key insights

Estimated biotech share of global pharma sales in 2024
41%
Biotech venture capital raised in the U.S. and Europe combined in 2023
18.9bn USD
Top company by gain on the 2020 Nasdaq Biotech Index
Novavax

Editor’s Picks
Editor’s Picks
Current statistics on this topic

Recommended statistics

Biotech market

SME financing

  • Basic Statistic Total raised capital in U.S. and Europe biotechnology industry 2015-2023
  • Basic Statistic IPOs in U.S. and Europe biotechnology industry 2000-2023
  • Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2023
  • Basic Statistic United States biotech financing data 2015-2020
  • Premium Statistic Value of top U.S. biotech IPOs 2023
  • Basic Statistic U.S. investment for emerging therapeutic companies 2011-2023

Research & development

  • Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2023
  • Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug owner
  • Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug originator
  • Basic Statistic Origin of new drugs licensed or acquired, 2014-2018, by company size
  • Basic Statistic Alliances U.S. and Europe biotech companies by total potential value 2023

Growth

BioNTech vs. Moderna

  • Basic Statistic Revenue of BioNTech 2017-2023
  • Basic Statistic Moderna's revenue 2016-2023
  • Basic Statistic Operating income of BioNTech 2017-2023
  • Basic Statistic Moderna net income 2016-2023
  • Basic Statistic Total assets of BioNTech 2017-2023
  • Basic Statistic Moderna total assets 2016-2023
  • Basic Statistic R&D expenses of BioNTech 2017-2023
  • Basic Statistic R&D expenses of Moderna 2016-2023

Comparison of COVID-19 vaccines

  • Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
  • Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
  • Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
  • Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
  • Basic Statistic Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)